The Zendal business model is based on research, development, manufacturing and marketing of biological products and vaccines.

Scientific excellence applied to biotechnology for human and animal healthcare

1st

SCIENTIFIC EXCELLENCE APPLIED TO BIOTECHNOLOGY FOR HUMAN AND ANIMAL HEALTHCARE

11%

INVESTMENT IN R&D&I

+300

STAFF

15

PRODUCTION LINES

+85000m2

PRODUCTION PLANTS

150Million

DIAGNOSE DOSES OF TUBERCULIN PER YEAR

Contract manufacturing

Biological production plants

We produce a wide range of pharmaceutical and biological products for large multinational companies and governments worldwide

We produce a wide range of pharmaceutical and biological products for large multinational companies and governments worldwide

Go to Contract Manufacturing

I+D+i

Scientific excellence

Human and animal healthcare
Viral, bacterial and parasitic vaccines
Genetic engineering, live attenuated vaccines
Subunit vaccines. State-of-the-art DNA vaccines
Platform for manufacturing vaccines against emerging illnesses
Open innovation

CDMO manufacturing for third parties

R&D: MANUFACTURING: REGULATORY: MARKETING: